PA1000 (Ethosuximide 250 mg)
Pill imprint PA1000 has been identified as Ethosuximide 250 mg.
Ethosuximide is used in the treatment of seizures and belongs to the drug class succinimide anticonvulsants. FDA has not classified the drug for risk during pregnancy. Ethosuximide 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- PA1000
- Strength:
- 250 mg
- Color:
- Orange
- Size:
- 9.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Succinimide anticonvulsants
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pliva Inc.
- National Drug Code (NDC):
- 50111-0901
- Inactive Ingredients:
- polyethylene glycol
FD&C Yellow No. 6
gelatin
glycerin
Note: Inactive ingredients may vary.
More about ethosuximide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 8 Reviews – Add your own review/rating
- Drug class: succinimide anticonvulsants
Consumer resources
Other brands: Zarontin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
